Competitive enrollment analysis tools for clinical trials

Most recruitment delays are not caused by a bad protocol. They are caused by the same eligible patients being asked to join three other studies at the same clinic. A feasibility lead who sees that early can change the country mix, loosen a criterion or pick different sites. One who sees it after first patient in is explaining a delay.

A useful competitive enrollment view answers five things:

• How many active or recruiting trials target the same condition, line of therapy and biomarker?
• What are their registered enrollment targets and start dates?
• Which countries and, where listed, which sites do they use?
• Which are sponsor programs with big budgets and which are small academic studies?
• When are the rival trials expected to complete and release those sites?

Registries hold the raw answer. The work is collecting it across three registries and keeping it current.

Categories are described from general knowledge of the market. Check each vendor for current features and prices.

Most feasibility groups need two layers: registry level competition, which a cited tool covers, and site level performance, which needs enterprise data or direct site contact. Buying the first does not remove the second, but it shows you which sites are worth asking about.

• Define the patient population the way a recruiter would: condition, stage, prior therapy, biomarker.
• Run the clinical trial search for that population and keep only recruiting, not yet recruiting and active trials.
• Open the trial table and filter by phase and country. Sum registered enrollment targets per country to see where demand for patients is heaviest.
• Separate sponsor programs from academic studies. Sponsor programs open more sites and pay more attention to speed.
• Note completion dates. A competing trial that ends in six months frees its sites for you.
• Save the question and turn on alerts, because new competitors keep registering after your first pass.
• Export the table into the feasibility report or the bid response.

Registered enrollment is a target, not a result, and registries are updated at different speeds. Treat the output as a map of competition rather than a forecast of accrual.

CRO feasibility managers use it to back a bid with a competing trial count instead of a guess. Sponsor clinical operations teams use it before choosing countries. Small biotechs without a feasibility department use it to defend a recruitment timeline to investors. The CRO use case and the clinical trial feasibility software page cover these workflows in more detail.

Teams that already hold an enterprise license for site data often add a cited registry tool for quick questions, because it takes a minute rather than an analyst request. If your main need is rival programs rather than enrollment, read the competitor clinical trial tracking software page.

The table is only the start. Protocol drafts, country regulatory notes and site questionnaires pile up alongside it, and teams spend real time searching those files. A tool that lets you ask questions of your protocol and feasibility documents keeps that internal material searchable in one place, while ClinicalEvidence stays on the public registry side. Keep confidential documents out of any tool your company has not approved.

Clinician costs 49 USD per month or 24 USD per month billed yearly. Research Team costs 199 USD per month or 99 USD per month billed yearly and pools 800 answers across 3 seats, which suits a feasibility lead, an analyst and a project manager. Organization costs 499 USD per month or 249 USD per month billed yearly for 10 seats and an audit log. See pricing for limits.

What are competitive enrollment analysis tools?

They collect registered competing trials for a condition, with enrollment targets, status, countries and sponsors, so a team can judge patient competition before finalizing a recruitment plan. Options range from free registry sites and spreadsheets to enterprise platforms and cited tools such as ClinicalEvidence.

How do you analyze competing trials for enrollment?

Define the patient population, search the registries for recruiting and upcoming trials, then total registered enrollment by country and separate sponsor programs from academic studies. Note completion dates, since ending trials release sites. Repeat on a schedule or use alerts.

Can ClinicalEvidence predict my enrollment rate?

No. It shows which trials compete for the same patients and where, with sources. It does not hold site performance or patient claims data, so accrual forecasting needs other inputs.

Does it cover trials outside the United States?

Yes. It covers the EU Clinical Trials Register and WHO ICTRP alongside ClinicalTrials.gov, which matters when your countries are in Europe or Asia.

How much does competitive enrollment analysis cost?

Registry sites are free but cost analyst time. ClinicalEvidence Clinician is 49 USD per month or 24 USD per month billed yearly, and Research Team is 199 USD per month or 99 billed yearly for 3 seats. Enterprise platforms are priced by quote.